Skip to main content
. 2017 May 19;8(43):73860–73870. doi: 10.18632/oncotarget.18008

Table 1. Correlation of mRNA expressions of p57Kip2 and CyclinD1 with clinicopathological features of GCA.

Clinicopathological features n Relative expression of CyclinD1 P Relative expression of p57/Kip2(%) P
Age (year) 0.320 0.586
< 60 11 6.825 ± 1.121 6.456 ± 1.031
≥ 60 21 6.995 ± 1.157 6.359 ± 1.157
Male/female 0.218 0.353
Male 30 7.121 ± 1.058 6.268 ± 1.227
Female 2 6.877 ± 1.203 6.448 ± 1.090
The stomach diseases 0.307 0.310
No 12 6.827 ± 1.214 6.516 ± 1.012
Yes 20 6.993 ± 1.124 6.209 ± 1.272
Family history of cancer 0.445 0.162
No 19 6.895 ± 1.212 6.451 ± 1.147
Yes 13 6.996 ± 1.130 6.173 ± 1.248
Pathological grade differentiated 0.312 0.032
Middle-low differentiated 7 6.988 ± 1.133 6.083 ± 1.215
High-middle differentiated 25 6.810 ± 1.209 6.513 ± 1.012
Clinical stage 0.021 0.697
< IIIb 15 6.620 ± 1.214 6.408 ± 0.127
≥ IIIb 17 7.283 ± 1.131 6.363 ± 0.138
Lymph node metastasis 0.042 0.068
Negative 8 6.493 ± 1.169 6.521 ± 1.009
Positive 24 6.876 ± 1.140 6.091 ± 1.185